1
However, there is growing interest in using real-world data for relative effectiveness assessment.
2
Possible selection bias limits any conclusions about relative effectiveness or cost-effectiveness.
3
Key model inputs include relative effectiveness of competing treatments, typically informed by meta-analysis.
4
The smokers also provided self-report predictions of the campaigns' relative effectiveness.
5
Their relative effectiveness and comparability based on squamous versus nonsquamous histology is uncertain.
6
Little is known about the relative effectiveness of these provocative agents in unmasking Brugada syndrome.
7
Objectives: To investigate the relative effectiveness of the use of real or placebo CPAP on daytime sleepiness.
8
Objective: We assessed the extent to which social media-generated health data has provided insights for relative effectiveness assessment.
9
The results were sensitive to the higher relative effectiveness estimated for eplerenone compared with spironolactone from the meta-regression.
10
Background: An element of health technology assessment constitutes assessing the clinical effectiveness of drugs, generally called relative effectiveness assessment.
11
Background: In many European jurisdictions, relative effectiveness assessments (REAs) of pharmaceuticals are performed during the reimbursement decision-making process.
12
To provide a framework for evaluating the relative effectiveness and costs associated with candidate postexposure prophylaxis (PEP) regimens.
13
This potential has not yet been fully realized and the degree of usefulness for relative effectiveness assessment should be further explored.
14
Little real-world evidence is available directly after market access, therefore randomized controlled trials are used to obtain information for relative effectiveness assessment.
15
Rationale: The relative effectiveness of the atypical antipsychotic drugs and conventional agents in patients with early-stage schizophrenia has not been comprehensively determined.
16
There is a full model and a focused rapid relative effectiveness assessment model, and a third joint action is to continue till 2020.
